Bli medlem
Bli medlem

Du är här

2021-09-08

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

BEND, Ore., Sept. 08, 2021 (GLOBE NEWSWIRE) --

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.    KEY INFORMATION

Name of person dealing (Note 1)Stonepine Capital, L.P.
Company dealt inStrongbridge Biopharma plc
Class of relevant security to which the dealings being disclosed relate (Note 2)Ordinary Shares
Date of dealingSale - 7/09/2021

2.    INTERESTS AND SHORT POSITIONS

(a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 LongShort
 Number(%)Number(%)
(1) Relevant securities4,593,0906.78%0
(2) Derivatives (other than options) 00
(3) Options and agreements to purchase/sell 00
Total4,593,0906.78%0

(b)    Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
 Number
(%)Number
(%)
(1) Relevant securitiesN/AN/A
(2) Derivatives (other than options)
Författare GlobeNewswire

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.